Sun Pharma Appoints Satyavati Berera as Independent Director

Sun Pharmaceutical Industries announced the appointment of Ms. Satyavati Berera as an Independent Director for a five-year term, subject to shareholder approval.
The appointment was approved by the company's Board of Directors on April 4, 2026, and will be effective from the date of shareholder approval via postal ballot.
The appointment is intended to strengthen the Board's independence and governance, and the company states it complies with SEBI and Companies Act requirements.